NovoCure Limited

BMV:NVCR N 株式レポート

時価総額:Mex$27.1b

NovoCure 過去の業績

過去 基準チェック /06

NovoCure's earnings have been declining at an average annual rate of -41.4%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 14.5% per year.

主要情報

-41.4%

収益成長率

-37.7%

EPS成長率

Medical Equipment 業界の成長12.9%
収益成長率14.5%
株主資本利益率-50.1%
ネット・マージン-39.1%
前回の決算情報30 Sep 2023

最近の業績更新

Recent updates

収支内訳

NovoCure の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

BMV:NVCR N 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 23504-197380224
30 Jun 23508-174354222
31 Mar 23522-141331224
31 Dec 22538-93306206
30 Sep 22543-82289208
30 Jun 22545-68279204
31 Mar 22538-59269198
31 Dec 21535-58263201
30 Sep 21546-27253188
30 Jun 21545-5246173
31 Mar 2152712232153
31 Dec 2049420225132
30 Sep 2045019216112
30 Jun 204091220698
31 Mar 20380919787
31 Dec 19351-718579
30 Sep 19322-2717470
30 Jun 19294-4116665
31 Mar 19269-5515857
31 Dec 18248-6415151
30 Sep 18232-5914346
30 Jun 18217-5913742
31 Mar 18194-6413140
31 Dec 17177-6212338
30 Sep 17154-7311537
30 Jun 17125-9511237
31 Mar 17105-11410839
31 Dec 1683-13210741
30 Sep 1665-14310844
30 Jun 1652-1359644
31 Mar 1641-1248545
31 Dec 1533-1127344
30 Sep 1525-1026044
30 Jun 1520-945343
31 Mar 1518-864941
31 Dec 1415-814540
31 Dec 1310-773335

質の高い収益: NVCR N is currently unprofitable.

利益率の向上: NVCR N is currently unprofitable.


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: NVCR N is unprofitable, and losses have increased over the past 5 years at a rate of 41.4% per year.

成長の加速: Unable to compare NVCR N's earnings growth over the past year to its 5-year average as it is currently unprofitable

収益対業界: NVCR N is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).


株主資本利益率

高いROE: NVCR N has a negative Return on Equity (-50.11%), as it is currently unprofitable.


総資産利益率


使用総資本利益率


過去の好業績企業の発掘